Free Trial
NASDAQ:TLX

Telix Pharmaceuticals (TLX) Stock Price, News & Analysis

Telix Pharmaceuticals logo
$11.97 -0.29 (-2.37%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$12.80 +0.83 (+6.93%)
As of 04:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Telix Pharmaceuticals Stock (NASDAQ:TLX)

Key Stats

Today's Range
$11.83
$12.25
50-Day Range
$11.97
$17.48
52-Week Range
$11.83
$30.36
Volume
134,910 shs
Average Volume
63,106 shs
Market Capitalization
$4.05 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.33
Consensus Rating
Buy

Company Overview

Receive TLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TLX Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
Telix H1 2025 Results: Investor Webcast Notification
See More Headlines

TLX Stock Analysis - Frequently Asked Questions

Telix Pharmaceuticals' stock was trading at $15.40 at the beginning of 2025. Since then, TLX stock has decreased by 22.3% and is now trading at $11.97.

Telix Pharmaceuticals (TLX) raised $202 million in an initial public offering on Friday, June 14th 2024. The company issued 17,000,000 shares at a price of $11.87 per share.

Top institutional shareholders of Telix Pharmaceuticals include Pier Capital LLC (0.06%), Vanguard Personalized Indexing Management LLC (0.01%) and Blair William & Co. IL.

Shares of TLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/07/2025
Next Earnings (Estimated)
8/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TLX
Previous Symbol
NASDAQ:TLX
CIK
2007191
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$23.00
Low Price Target
$22.00
Potential Upside/Downside
+86.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.99
Current Ratio
2.78
Quick Ratio
2.66

Sales & Book Value

Annual Sales
$516.72 million
Price / Sales
7.84
Cash Flow
$0.11 per share
Price / Cash Flow
107.36
Book Value
$1.12 per share
Price / Book
10.69

Miscellaneous

Outstanding Shares
338,400,000
Free Float
N/A
Market Cap
$4.05 billion
Optionable
N/A
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:TLX) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners